• Mi Re-Unir
    Búsqueda Avanzada
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Ver ítem 
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem

    Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia

    Autor: 
    Santos-Zorrozua, Borja
    ;
    González-Fraile, Eduardo
    ;
    Zabala, Arantzazu
    ;
    Guillén, Virginia
    ;
    Rueda, Jose R.
    ;
    Ballesteros, Javier
    Fecha: 
    11/2018
    Palabra clave: 
    meta-analysis; randomised controlled trials; acetylcholinesterase inhibitors; galantamine; donepezil; rivastigmine; cognitive impairment; psychosis; JCR; Scopus
    Revista / editorial: 
    Journal of Psychopharmacology
    Tipo de Ítem: 
    Articulo Revista Indexada
    URI: 
    https://reunir.unir.net/handle/123456789/7946
    DOI: 
    http://dx.doi.org/10.1177/0269881118805496
    Dirección web: 
    https://journals.sagepub.com/doi/10.1177/0269881118805496
    Resumen:
    Background: Schizophrenia is a severe, persistent mental disorder, and a leading cause of disability worldwide. Cognitive impairments presented in schizophrenia lead to a worse prognostic, thus treatments targeted to enhance cognition in schizophrenia may be clinically relevant. Aims: The purpose of this study was to assess the efficacy of acetylcholinesterase inhibitors as add-on medication to antipsychotics on cognition in patients with schizophrenia. Methods: Search strategies were developed for Medline, Embase and Cochrane Central Register of Controlled Trials, and are current to March 2018. We included randomised controlled trials that compared antipsychotics plus acetylcholinesterase inhibitors versus antipsychotics plus placebo on prespecified cognitive domains (speed of processing, attention and working memory). Two review authors independently evaluated study eligibility, extracted data and assessed the risk of bias of included studies. We used random-effects model for meta-analyses and assessed the quality of evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE). Results: We included nine randomised controlled trials. Six randomised controlled trials (n=219) presented evidence that acetylcholinesterase inhibitors improve speed of processing (standardised mean difference -0.52, 95% confidence interval (-0.79 to -0.25); p value=0.0002). However, eight randomised controlled trials (n=252) did find placebo was better than acetylcholinesterase inhibitors in the attention domain (-0.43, (-0.72 to -0.13); p value=0.005) and eight randomised controlled trials (n=273) did not find differences in the working memory (-0.14, (-0.51 to 0.24), p value=0.47). Conclusions: The current evidence is too weak to base recommendations on the use of acetylcholinesterase inhibitors as adjunctive treatments to antipsychotics to improve basic cognitive functions. We have limited confidence in the effect estimates.
    Mostrar el registro completo del ítem
    Este ítem aparece en la(s) siguiente(s) colección(es)
    • Artículos Científicos WOS y SCOPUS

    Estadísticas de uso

    Año
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    Vistas
    0
    0
    0
    0
    0
    0
    0
    83
    47
    35
    44
    46
    68
    54
    Descargas
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0

    Ítems relacionados

    Mostrando ítems relacionados por Título, autor o materia.

    • Remotely delivered information, training and support for informal caregivers of people with dementia 

      González-Fraile, Eduardo ; Ballesteros, Javier; Rueda, Jose R.; Santos-Zorrozua, Borja; Solà, Ivan; McCleery, Jenny (Cochrane database of systematic reviews, 2021)
      Many people with dementia are cared for at home by unpaid informal caregivers, usually family members. Caregivers may experience a range of physical, emotional, financial and social harms, which are often described ...
    • Assessment of the consequences of caregiving in psychosis: a psychometric comparison of the Zarit Burden Interview (ZBI) and the Involvement Evaluation Questionnaire (IEQ) 

      Gonçalves-Pereira, Manuel; González-Fraile, Eduardo ; Santos-Zorrozua, Borja; Martín-Carrasco, Manuel; Fernández-Catalina, Paola; Domínguez-Panchón, Ana I; Muñoz-Hermoso, Paula; Ballesteros, Javier (Health and Quality of Life Outcomes, 04/2017)
      Background: The Zarit Burden Interview ( ZBI) was originally developed to assess the level of subjective burden in caregivers of people with dementia. The Involvement Evaluation Questionnaire ( IEQ) is amongst the leading ...
    • Agreement between clinician-centred and patient-centred depressive symptoms scales 

      Arostegui, S; González-Fraile, Eduardo ; Sanz-Arzuaga, C; Intxauspe, L; Ballesteros, Javier; Santos-Zorrozua, Borja (European Neuropsychopharmacology, 2019)
      Ponencia en el congreso "31st Congress of the European-College-of-Neuropsychopharmacology (ECNP)"

    Mi cuenta

    AccederRegistrar

    ¿necesitas ayuda?

    Manual de UsuarioContacto: reunir@unir.net

    Listar

    todo Re-UnirComunidades y coleccionesPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de accesoEsta colecciónPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de acceso






    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja
     
    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja